40
Participants
Start Date
June 11, 2018
Primary Completion Date
June 10, 2025
Study Completion Date
June 10, 2026
Gemcitabine-Oxaliplatin Regimen
"Vascularisation of hepatic tumors is almost exclusively provided by the hepatic artery.~Gemcitabine and oxaliplatin have a high rate of hepatic extraction during the first passage, thus allowing the drugs to reach high intra-tumoral concentrations with low systemic toxicity."
Hepatic intra arterial chemotherapy
"The implantation of a hepatic arterial catheter has now been mastered by interventional radiologists and makes it possible to increase the intra-tumoral concentration of the drugs and probably to limit their systemic toxicity.~Very recently, we have reported that this combination in progressive IHC following systemic gemcitabine/oxaliplatin has led to partial responses and allowed certain patients to benefit from curative treatment.~This suggests that the intra-arterial approach increases the efficacy of these 2 drugs. For locally-advanced IHC, such a loco-regional approach is worth exploring in this poor-prognosis tumor."
RECRUITING
Uhmontpellier, Montpellier
RECRUITING
Amiens University Hospital, Amiens
RECRUITING
Angers University Hospital, Angers
RECRUITING
Bordeaux University Hospital, Bordeaux
RECRUITING
Centre Georges François Leclerc, Dijon
RECRUITING
Hôpital Européen Georges Pompidou, Paris
RECRUITING
Institut Gustave Roussy, Villejuif
Federation Francophone de Cancerologie Digestive
OTHER
University Hospital, Montpellier
OTHER